Clinical Trial Update: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topical sirolimus for early-stage cutaneous T-cell lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Stefan Schieke MD | Conditions: Cutaneous T-cell Lymphoma (CTCL) | Phase 2 | Status: WITHDRAWN